Within the 2021 classification of CNS tumors, two novel embryonal tumors have been added: CNS neuroblastoma, FOXR2-activated and CNS tumor with BCOR internal tandem duplication. This evidence concerns the gene FOXR2 and central nervous system neoplasm.